检索结果 - Robert Dreicer

Refine Results
  1. 1
    Chemotherapy for multiple myeloma

    Chemotherapy for multiple myeloma 由 Raymond Alexanian, Robert Dreicer

    出版 1984
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Renal cell carcinoma for the nephrologist

    Renal cell carcinoma for the nephrologist 由 Mark A. Perazella, Robert Dreicer, Mitchell H. Rosner

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    <i>HER2</i>Overexpression and Amplification in Urothelial Carcinoma of the Bladder Is Associated With<i>MYC</i>Coamplification in a Subset of Cases

    <i>HER2</i>Overexpression and Amplification in Urothelial Carcinoma of the Bladder Is Associated With<i>MYC</i>Coamplification in a Subset of Cases 由 Donna E. Hansel, Eric Swain, Robert Dreicer, Raymond R. Tubbs

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer

    A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer 由 William R. Schelman, Glenn Liu, George Wilding, Thomas Morris, De Phung, Robert Dreicer

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Phase 2 trial of epothilone B analog BMS‐247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800)

    Phase 2 trial of epothilone B analog BMS‐247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800) 由 Robert Dreicer, Shuli Li, Judith Manola, Naomi B. Haas, Bruce J. Roth, George Wilding

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896)

    Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896) 由 David J. Vaughn, Judith Manola, Robert Dreicer, William A. See, Ralph Levitt, George Wilding

    出版 2002
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Phase 2 trial of sorafenib in patients with advanced urothelial cancer

    Phase 2 trial of sorafenib in patients with advanced urothelial cancer 由 Robert Dreicer, Hailun Li, Mark N. Stein, Robert S. DiPaola, Michael Eleff, Bruce J. Roth, George Wilding

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization

    HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization 由 Christina B. Ching, Mohammed A. Amin, Raymond R. Tubbs, Paul Elson, Eric Platt, Robert Dreicer, Amr Fergany, Donna E. Hansel

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium

    Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium 由 Robert Dreicer, Judith Manola, Bruce J. Roth, William A. See, Steven A. Kuross, Martin J. Edelman, Gary R. Hudes, George Wilding

    出版 2004
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

    Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib 由 Ila Tamaskar, Ronald M. Bukowski, Paul Elson, Adriana G. Ioachimescu, L. Wood, Robert Dreicer, Tarek Mekhail, J. Garcia, Brian I. Rini

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

    Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma 由 Matthew D. Galsky, G. J. Chen, William Oh, Joaquim Bellmunt, Bruce J. Roth, Roberto Petrioli, Luigi Dogliotti, Robert Dreicer, Guru Sonpavde

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib

    Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib 由 Jenny J. Kim, S. A. Vaziri, Brian I. Rini, Paul Elson, Jorge A. García, Robert Wirka, Robert Dreicer, Mahrukh K. Ganapathi, Ram Ganapathi

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

    Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib 由 Brian I. Rini, Ila Tamaskar, Phillip Shaheen, R. N. Salas, Jorge Garcia, Laura S. Wood, S. Sethu K. Reddy, Robert Dreicer, Ronald M. Bukowski

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

    Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases 由 James R. Berenson, Lee S. Rosen, Anthony Howell, Lester Porter, Robert E. Coleman, Walter Morley, Robert Dreicer, Steven A. Kuross, Allan Lipton, John J. Seaman

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer

    Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer 由 Zhenfei Li, Andrew C. Bishop, Mohammad Alyamani, Jorge A. García, Robert Dreicer, Dustin R. Bunch, Jiayan Liu, Sunil Upadhyay, Richard J. Auchus, Nima Sharifi

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab

    Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab 由 Jorge A. García, Thomas E. Hutson, Paul Elson, C. Lance Cowey, Timothy D. Gilligan, Cheryl Nemec, Robert Dreicer, Ronald M. Bukowski, Brian I. Rini

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review

    Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review 由 Mark Willy L. Mondia, Prem P. Batchala, Robert Dreicer, Michael Devitt, Matthew R McCord, Melike Mut, Jason P. Sheehan, David Schiff, Camilo E. Fadul

    出版 2025
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  18. 18
    Lack of pathologic down‐staging with neoadjuvant chemotherapy for muscle‐invasive urothelial carcinoma of the bladder

    Lack of pathologic down‐staging with neoadjuvant chemotherapy for muscle‐invasive urothelial carcinoma of the bladder 由 Christopher Weight, Jorge A. García, Donna E. Hansel, Amr Fergany, Steven C. Campbell, Michael Gong, J. Stephen Jones, Eric A. Klein, Robert Dreicer, Andrew J. Stephenson

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>

    The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells <i>In Vitro</i> and <i>In Vivo<... 由 Ning Zhou, Kamini Singh, Maria Carmen Mir, Yvonne Parker, Daniel J. Lindner, Robert Dreicer, Jeffrey Ecsedy, Zhongfa Zhang, Bin Tean Teh, Alexandru Almasan, Donna E. Hansel

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    A Transient Increase in Eosinophils Is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T

    A Transient Increase in Eosinophils Is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T 由 Douglas G. McNeel, Thomas A. Gardner, Celestia S. Higano, Philip W. Kantoff, Eric J. Small, Mark H. Wener, Robert B. Sims, Todd DeVries, Nadeem A. Sheikh, Robert Dreicer

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: